Experiencia inicial con cinacalcet en Argentina / Inicial experience with cinacalcet in Argentina
Rev. nefrol. diál. traspl
;
35(1): 15-23, ene. 2015. ilus, tab
Article
in Spanish
| LILACS
| ID: biblio-908365
RESUMEN
Introducción:
el hiperparatiroidismo secundarioes una complicación frecuente de laenfermedad renal crónica. Cinacalcet, un moduladoralostérico del receptor sensor del calcio incrementasu sensibilidad a la activación por partedel calcio iónico extracelular, demostró ser efectivoen reducir los niveles de PTH.Objetivo:
Evaluar la eficacia de cinacalcet en pacientes enhemodiálisis con HPTS. Material ymétodos:
Se realizó un estudio retrospectivo, multicéntrico, observacional, en 76 pacientes que recibieronal menos 3 meses de cinacalcet como tratamientodel HPTS...ABSTRACT
Introduction:
secondary Hyperparathyroidism is a frequent chronic renal disease complication. Cinacalcet, an allosteric modulator of the calcium sensing receptor, increases its sensitivity to activation by extracellular calcium ions, proved to be effective in reducing PTH levels. Objetive To evaluate cinacalcet effectiveness in hemodialysis patients with HPTS.Methods:
A retrospective, multicenter, observational study was carried out, on 76 patients who received Cinacalcet for at least 3 months, as a treatment for HPTS...
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Therapeutics
/
Calcium Metabolism Disorders
/
Drug Therapy
/
Renal Insufficiency, Chronic
/
Hyperparathyroidism, Secondary
Type of study:
Controlled clinical trial
/
Observational study
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
South America
/
Argentina
Language:
Spanish
Journal:
Rev. nefrol. diál. traspl
Journal subject:
General Surgery
/
Nephrology
Year:
2015
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Fresenius Medical Care/AR
/
Grupo de Metabolismo Ëseo Mineral/AR
/
Instituto de Diagnóstico e Investigaciones Metabólicas/AR
/
Servicio de Nefrología/AR
Similar
MEDLINE
...
LILACS
LIS